Successful treatment of atopic dermatitis by switching from upadacitinib to abrocitinib: a case report

Eur J Dermatol. 2023 Dec 1;33(6):699-701. doi: 10.1684/ejd.2023.4581.

Authors

Ya-Chu Tsai¹, Tsen-Fang Tsai²

Affiliations

¹ Department of Dermatology, Far Eastern Memorial Hospital, New Taipei, Taiwan, Minghsin University of Science and Technology, Hsinchu, Taiwan.
² Department of Dermatology, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.

PMID: 38465559
DOI: 10.1684/ejd.2023.4581

No abstract available

Publication types

Case Reports

MeSH terms

Dermatitis, Atopic* / drug therapy
Double-Blind Method
Heterocyclic Compounds, 3-Ring
Humans
Pyrimidines / therapeutic use
Severity of Illness Index
Sulfonamides*
Treatment Outcome

Substances

abrocitinib
upadacitinib
Heterocyclic Compounds, 3-Ring
Pyrimidines
Sulfonamides